Content
08/04/2024 Boston, MA USA
GRO Biosciences completed $60 million Series B Round funding. Investors include Atlas Venture (lead), Access Industries (lead), Digitalis Ventures, Innovation Endeavors, Leaps by Bayer.
#Biotech  #Life Science  
About
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
Startup
GRO Biosciences
https://grobio.com Claim Profile
Location:
Boston, MA USA
Sector:
Biotech
Life Science
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.